6.5 C
New York
Monday, June 21, 2021

Israel investigates cases of heart inflammation in people who received 2nd dose of Pfizer COVID vaccine

In Israel, about 74% of the country's adult population was fully vaccinated

Must Read

Aakash Molpariya
Aakash started in Nov 2018 as a writer at Revyuh.com. Since joining, as writer, he is mainly responsible for Software, Science, programming, system administration and the Technology ecosystem, but due to his versatility he is used for everything possible. He writes about topics ranging from AI to hardware to games, stands in front of and behind the camera, creates creative product images and much more. He is a trained IT systems engineer and has studied computer science. By the way, he is enthusiastic about his own small projects in game development, hardware-handicraft, digital art, gaming and music. Email: aakash (at) revyuh (dot) com

Most cases of myocarditis have been reported among Israelis under the age of 30, the Ministry of Health said.

In Israel, dozens of cases of heart inflammation have been detected among more than 5 million people vaccinated against coronavirus, mainly after the second dose of the drug from Pfizer. This is reported by Reuters with reference to the Israeli Ministry of Health on Monday, April 26.

“The Health Ministry is currently examining whether there is an excess in morbidity (disease rate) and whether it can be attributed to the vaccines,” said Nachman Ash, Israel’s pandemic program coordinator, adding that no conclusions have been drawn so far.

According to him, most cases of myocarditis are registered among people under the age of 30. However, it will be difficult to determine the link between heart disease and vaccination, because myocarditis can be caused by various viruses. A similar number of cases of heart inflammation have been reported in previous years, Nachman Ash added.

Pfizer said it is in regular contact with the Israeli Ministry of Health to verify the data on its vaccine. In particular, the company said it was “aware of Israeli observations of myocarditis, which occurred primarily among young people who received the Pfizer-BioNTech COVID-19 vaccine.”

“Adverse events are regularly and thoroughly reviewed and we have not observed a higher rate of myocarditis than what would be expected in the general population. A causal link to the vaccine has not been established”

the company said.

“There is no evidence at this time to conclude that myocarditis is a risk associated with the use of Pfizer/BNT COVID-19 vaccine.”

“It’s a situation that should be looked into, and we need to wait for a final report, but in an interim analysis it seems the risk of getting sick from COVID-19 is much higher than from the vaccine’s adverse events, and the risk of peri/myo-carditis following the vaccine is low and temporary”

said Nadav Davidovitch, director of the school of public health at Israel’s Ben Gurion University.

As you know, Israel is one of the world leaders in vaccination against coronavirus. More than 5.3 million people received the first dose of the vaccine, and 5 million people received the second dose. 

Fully vaccinated about 54% of the country’s population and about 74% of the adult population (over 16 years old).

- Advertisement -
- Advertisement -

Latest News

Nutritionist reveals the danger of brown bread

Diabetics are advised to replace white bread with brown bread, but many of its types often contain harmful additives,...
- Advertisement -

More Articles Like This

- Advertisement -